IceCure Medical Ltd (ICCM)
USD 1.14
(-7.67%)
USD 1.14
(-7.67%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 4.24 Million USD | -10.89% |
| 2022 | 4.76 Million USD | -10.46% |
| 2021 | 5.32 Million USD | -7.49% |
| 2020 | 5.75 Million ILS | 22.66% |
| 2019 | 4.69 Million ILS | 148.57% |
| 2018 | 1.88 Million ILS | -13.75% |
| 2017 | 2.18 Million ILS | 80.85% |
| 2016 | 1.2 Million ILS | 0.66% |
| 2015 | 1.2 Million ILS | -17.9% |
| 2014 | 1.46 Million ILS | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 4.73 Million USD | 8.5% |
| 2024 Q1 | 4.37 Million USD | 3.92% |
| 2023 Q4 | 4.21 Million USD | -9.11% |
| 2023 FY | 4.24 Million USD | -10.89% |
| 2023 Q2 | 4.25 Million USD | -12.61% |
| 2023 Q1 | 4.86 Million USD | 2.14% |
| 2023 Q3 | 4.63 Million USD | 8.93% |
| 2022 Q1 | 5.74 Million USD | 7.98% |
| 2022 FY | 4.76 Million USD | -10.46% |
| 2022 Q3 | 4.8 Million USD | -2.61% |
| 2022 Q4 | 4.76 Million USD | -0.87% |
| 2022 Q2 | 4.93 Million USD | -14.11% |
| 2021 FY | 5.32 Million USD | -7.49% |
| 2021 Q3 | 18.89 Million USD | 15.22% |
| 2021 Q4 | 5.32 Million USD | -71.83% |
| 2021 Q2 | 16.4 Million USD | 0.0% |
| 2021 Q1 | - USD | -100.0% |
| 2020 Q3 | - USD | -100.0% |
| 2020 Q4 | 5.75 Million ILS | 0.0% |
| 2020 FY | 5.75 Million ILS | 22.66% |
| 2020 Q1 | 21.62 Million USD | 361.0% |
| 2020 Q2 | 6.27 Million ILS | -71.01% |
| 2019 Q4 | 4.69 Million ILS | -71.12% |
| 2019 FY | 4.69 Million ILS | 148.57% |
| 2019 Q1 | 8.56 Million USD | 353.82% |
| 2019 Q2 | 2.39 Million ILS | -72.02% |
| 2019 Q3 | 16.24 Million USD | 577.84% |
| 2018 Q4 | 1.88 Million ILS | -47.31% |
| 2018 Q2 | 1.55 Million ILS | -49.01% |
| 2018 Q1 | 3.04 Million USD | 39.16% |
| 2018 Q3 | 3.58 Million USD | 130.7% |
| 2018 FY | 1.88 Million ILS | -13.75% |
| 2017 FY | 2.18 Million ILS | 80.85% |
| 2017 Q1 | 3.78 Million USD | 212.59% |
| 2017 Q4 | 2.18 Million ILS | -55.85% |
| 2017 Q2 | 1.8 Million ILS | -52.3% |
| 2017 Q3 | 4.95 Million USD | 174.72% |
| 2016 Q3 | 683.08 Thousand USD | -0.69% |
| 2016 Q4 | 1.2 Million ILS | 77.12% |
| 2016 FY | 1.2 Million ILS | 0.66% |
| 2016 Q2 | 687.85 Thousand USD | -19.24% |
| 2016 Q1 | 851.7 Thousand USD | 30.68% |
| 2015 FY | 1.2 Million ILS | -17.9% |
| 2015 Q3 | 723.07 Thousand USD | -7.75% |
| 2015 Q2 | 783.85 Thousand USD | 1.24% |
| 2015 Q1 | 774.26 Thousand USD | -74.37% |
| 2015 Q4 | 651.75 Thousand USD | -9.86% |
| 2014 FY | 1.46 Million ILS | 0.0% |
| 2014 Q4 | 3.02 Million USD | 13.66% |
| 2014 Q3 | 2.65 Million USD | 9.47% |
| 2014 Q2 | 2.42 Million USD | -0.33% |
| 2014 Q1 | 2.43 Million USD | 30.9% |
| 2013 Q1 | 1.98 Million USD | -24.72% |
| 2013 Q2 | 1.57 Million USD | -20.64% |
| 2013 Q3 | 2.11 Million USD | 34.07% |
| 2013 Q4 | 1.86 Million USD | -11.93% |
| 2012 Q4 | 2.63 Million USD | 20.9% |
| 2012 Q3 | 2.18 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 91.714% |
| BrainsWay Ltd. | 15.31 Million USD | 72.267% |
| Cerus Corporation | 144.3 Million USD | 97.057% |
| Envoy Medical, Inc. | 9.4 Million USD | 54.829% |
| electroCore, Inc. | 8.94 Million USD | 52.521% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | 20.498% |
| Inogen, Inc. | 121.38 Million USD | 96.501% |
| OrthoPediatrics Corp. | 72.56 Million USD | 94.147% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 85.643% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -33.472% |
| MaxCyte, Inc. | 36.1 Million USD | 88.238% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -129.827% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -898.634% |
| Orthofix Medical Inc. | 326.58 Million USD | 98.7% |
| PAVmed Inc | 57.13 Million USD | 92.567% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 83.321% |
| RxSight, Inc. | 22.18 Million USD | 80.859% |
| Sight Sciences, Inc. | 46.43 Million USD | 90.854% |
| SI-BONE, Inc. | 61.05 Million USD | 93.043% |
| TELA Bio, Inc. | 59.16 Million USD | 92.822% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 96.274% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | 58.843% |
| Acutus Medical, Inc. | 54.83 Million USD | 92.256% |
| Talis Biomedical Corporation | 29.22 Million USD | 85.467% |
| Spectral AI, Inc. | 12.4 Million USD | 65.753% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 81.642% |
| CVRx, Inc. | 39.28 Million USD | 89.188% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 64.484% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -74.824% |
| Bioventus Inc. | 589.79 Million USD | 99.28% |
| Venus Concept Inc. | 107.1 Million USD | 96.035% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 91.779% |
| LivaNova PLC | 1.15 Billion USD | 99.631% |
| 908 Devices Inc. | 37.49 Million USD | 88.672% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 99.396% |
| Nemaura Medical Inc. | 26.37 Million USD | 83.899% |
| NeuroPace, Inc. | 86.99 Million USD | 95.118% |
| LENSAR, Inc. | 22.4 Million USD | 81.048% |
| Apyx Medical Corporation | 52.31 Million USD | 91.882% |
| Cutera, Inc. | 518.12 Million USD | 99.18% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 85.519% |
| BioSig Technologies, Inc. | 4.68 Million USD | 9.349% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 92.724% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 80.235% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.806% |
| Axonics, Inc. | 82.35 Million USD | 94.843% |
| Outset Medical, Inc. | 190.91 Million USD | 97.775% |
| IRIDEX Corporation | 24.91 Million USD | 82.953% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 96.574% |
| IRadimed Corporation | 20.73 Million USD | 79.519% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -153.704% |
| INVO Bioscience, Inc. | 19.99 Million USD | 78.76% |
| Telesis Bio, Inc. | 40.87 Million USD | 89.609% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 89.588% |
| Varex Imaging Corporation | 668.6 Million USD | 99.365% |
| Quipt Home Medical Corp. | 136.29 Million USD | 96.884% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -18.897% |
| Pulmonx Corporation | 60.63 Million USD | 92.996% |
| Dynatronics Corporation | 11.78 Million USD | 63.948% |
| Modular Medical, Inc. | 2.27 Million USD | -86.928% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -4.503% |
| Semler Scientific, Inc. | 6.27 Million USD | 32.265% |
| InMode Ltd. | 75.91 Million USD | 94.406% |
| Bruker Corporation | 2.83 Billion USD | 99.85% |
| Cytosorbents Corporation | 29.98 Million USD | 85.836% |
| DexCom, Inc. | 4.19 Billion USD | 99.899% |
| Align Technology, Inc. | 2.45 Billion USD | 99.827% |
| Viveve Medical, Inc. | 10.84 Million USD | 60.846% |
| ZimVie Inc. | 795.85 Million USD | 99.466% |
| Movano Inc. | 5.97 Million USD | 28.885% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 95.94% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -898.634% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 64.484% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 99.335% |
| Profound Medical Corp. | 12.66 Million USD | 66.469% |
| Insulet Corporation | 1.85 Billion USD | 99.771% |
| enVVeno Medical Corporation | 2.43 Million USD | -74.415% |
| Surmodics, Inc. | 65.82 Million USD | 93.548% |
| iCAD, Inc. | 8 Million USD | 46.919% |
| Nuwellis, Inc. | 6.78 Million USD | 37.36% |
| Biotricity, Inc. | 35.91 Million USD | 88.176% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 98.096% |
| Aethlon Medical, Inc. | 2.47 Million USD | -71.274% |
| InspireMD, Inc. | 8.14 Million USD | 47.838% |
| PAVmed Inc. | 57.13 Million USD | 92.567% |
| BIOLASE, Inc. | 35.34 Million USD | 87.985% |
| Beyond Air, Inc. | 29.77 Million USD | 85.736% |
| FONAR Corporation | 57.45 Million USD | 92.608% |
| AxoGen, Inc. | 101.16 Million USD | 95.802% |
| Vivani Medical, Inc. | 25.03 Million USD | 83.036% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 95.163% |
| Inari Medical, Inc. | 209.32 Million USD | 97.971% |
| UFP Technologies, Inc. | 118.04 Million USD | 96.402% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 66.534% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -94.299% |
| Tenon Medical, Inc. | 5.56 Million USD | 23.711% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -138.73% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 75.916% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.865% |
| Sintx Technologies, Inc. | 6.59 Million USD | 35.583% |
| NanoVibronix, Inc. | 2.68 Million USD | -58.116% |
| Quanterix Corporation | 78.08 Million USD | 94.561% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -18.897% |
| Sensus Healthcare, Inc. | 4.88 Million USD | 13.06% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.593% |
| TransMedics Group, Inc. | 568.84 Million USD | 99.253% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 74.541% |
| NeuroMetrix, Inc. | 1.33 Million USD | -218.575% |
| Hyperfine, Inc. | 9.8 Million USD | 56.663% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 98.303% |
| Biomerica, Inc. | 2.66 Million USD | -59.482% |
| Bone Biologics Corporation | 831.4 Thousand USD | -410.824% |
| AVITA Medical, Inc. | 19.86 Million USD | 78.621% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -115.181% |
| Silk Road Medical, Inc | 114.15 Million USD | 96.28% |